Tramadol Hydrochloride Tablet, Coated
Product Images NDC 68071-4119

4 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 68071-4119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 4119 09 A201)

Pdp (68071 4119 09 A201)
Tramadol Hydrochloride 50 mg coated tablets label from NuCare Pharmaceuticals, Inc. The label shows a bottle sticker for 90 tablets with the NDC 68071-4119-9. The label includes warnings about habit forming potential, storage instructions to keep out of reach of children and store at controlled temperature, and identification details such as the lot number and expiration date placeholders.*
FDA Label Image

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)
Chemical structure of Tramadol Hydrochloride. The diagram shows the molecular structure with elements and bonds, including hydroxyl and methyl groups, and the hydrochloride component.*
FDA Label Image

Figure 1 (Tramadol HCl Tablets Usp 2)

Figure 1 (Tramadol HCl Tablets Usp 2)
A pharmacokinetic curve comparing plasma concentration (ng/mL) over time (hours) for Tramadol and its metabolite M1 after single and multiple doses. The graph shows concentration decline from 0 to 48 hours for Tramadol and M1, indicating different profiles for single versus multiple dosing.*
FDA Label Image

Figure 2 (Tramadol HCl Tablets Usp 3)

Figure 2 (Tramadol HCl Tablets Usp 3)
A line graph titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing the percent of subjects discontinuing treatment over days in a double-blind period. The x-axis is labeled 'Days in Double-Blind' ranging from 0 to 25, and the y-axis is labeled 'Percent Discontinuing' from 0 to 50 percent. The curve represents discontinuation rates up to 10 days at a dosage of 200 mg/day.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.